Discontinued — last reported Q4 '25
Operating Lease Liabilities (Current)
Edwards Lifesciences Operating Lease Liabilities (Current) decreased by 0.8% to $24.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.5%, from $23.70M to $24.30M. Over 5 years (FY 2020 to FY 2025), Operating Lease Liabilities (Current) shows relatively stable performance with a -2.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase suggests an expanding physical footprint or upcoming renewals, while a decrease may indicate store closures or a shift toward asset ownership.
Detailed definition
The portion of operating lease payments due within the next twelve months, representing the short-term obligation for re...
Peer comparison
Retail-heavy tech companies often show higher current lease liabilities compared to pure software firms due to physical storefront presence.
operating_lease_liabilities_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.10M | $24.20M | $25.50M | $23.90M | $23.30M | $23.50M | $25.50M | $25.10M | $24.30M | $24.30M | $24.90M | $24.80M | $21.50M | $24.20M | $23.40M | $23.70M | $25.90M | $26.80M | $24.50M | $24.30M |
| QoQ Change | — | -3.6% | +5.4% | -6.3% | -2.5% | +0.9% | +8.5% | -1.6% | -3.2% | +0.0% | +2.5% | -0.4% | -13.3% | +12.6% | -3.3% | +1.3% | +9.3% | +3.5% | -8.6% | -0.8% |
| YoY Change | — | — | — | — | -7.2% | -2.9% | +0.0% | +5.0% | +4.3% | +3.4% | -2.4% | -1.2% | -11.5% | -0.4% | -6.0% | -4.4% | +20.5% | +10.7% | +4.7% | +2.5% |
Operating Lease Liabilities (Current) at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's operating lease liabilities (current)?
- Edwards Lifesciences (EW) reported operating lease liabilities (current) of $24.30M in Q1 2026.
- How has Edwards Lifesciences's operating lease liabilities (current) changed year-over-year?
- Edwards Lifesciences's operating lease liabilities (current) increased by 2.5% year-over-year, from $23.70M to $24.30M.
- What is the long-term trend for Edwards Lifesciences's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Edwards Lifesciences's operating lease liabilities (current) has grown at a -2.1% compound annual growth rate (CAGR), from $27.20M to $24.50M.
- What does operating lease liabilities (current) mean?
- The amount of rent and lease payments the company must pay in the next year.